AAA closes €40m financing round to expand radiopharma activities
This article was originally published in Clinica
Executive Summary
Advanced Accelerator Applications (AAA) is stepping up global production of its PET and SPECT diagnostic imaging agents, as well as advancing clinical trials of its radiopharmaceutical drugs, after closing a €40m financing round.